How MedTech Teams Can Demonstrate Value with Site of Care Reimbursement Data

Reimbursement data gives MedTech teams the financial context needed to prove their product’s value to hospitals and health systems. As hospitals and health systems revise their budgets to plan for upcoming CMS cuts, this has become a critical factor for evaluating medtech. 

There are three key reimbursement categories — charged, allowed, and paid — and each provides a different level of insight of site of care financial realities.

‍

Charged Reimbursement Data: Understanding Billed vs. Real Value

What it means:
The charged amount represents what a site of care bills patients and payers for a service or procedure.

How it’s used:
While useful for understanding the pricing strategy or the most valuable procedures of a facility, charged data alone doesn’t show the true financial picture. MedTech teams can use this data to compare how facilities intend to price procedures before payer adjustments come into play, but should not factor it into an ROI proposal.

‍

Allowed Reimbursement Data: Benchmarking True Market Value

What it means:
The allowed amount is the total payment that a payer and patient agree to pay for a procedure, and is almost always less than the charged amount. 

How it’s used:
Allowed data shows what’s realistically reimbursed in the market, creating a benchmark for pricing and margin analysis. Unlike the static contract or menu prices most data providers offer, AcuityMD’s site of care reimbursement data is dynamic, continually updating to reflect denials, contract adjustments, and payer policies.

This level of precision helps MedTech commercial teams:

• Quantify financial value in real terms
• Identify facilities with higher reimbursement rates
• Build ROI models that align with a buyer’s actual financial framework

‍

‍

Paid Reimbursement Data: Real Revenue Insight for MedTech Teams

What it means:
Paid amount data — exclusive to AcuityMD — represents what a site of care actually collects from the payer. It accounts for only what a payer has paid to the site of care, not what the patient owes, and offers a clear view into the real revenue that a site receives from payers.

How it’s used:
This data allows MedTech reps to have the most realistic discussion of their technology’s ROI. It helps them:

• Determine if co-pay support or forgiveness programs might be needed
• Target facilities with optimal patient and procedure mixes for their technology
• Tailor reimbursement discussions to match real-world financial performance

‍

Turning Insight Into Action

MedTech commercial teams can now move beyond surface-level claims data and craft financial cases that resonate with CFOs, supply chain leaders, and clinical decision makers. 

In an environment where every dollar is scrutinized, the ability to show the exact value your technology delivers isn’t just helpful, it’s decisive. AcuityMD’s complete reimbursement data for both Medicare and commercial payers give your team the evidence to win that argument every time.

Ready to see how AcuityMD’s site of care reimbursement analytics can help your MedTech team target high-value sites and prove ROI? Request a demo today.